MindWalk reports strong growth in Q3 2026 and strengthens its AI strategy for drug discovery MindWalk Holdings Corp. ,a company specializing in AI-assisted biologic discovery and drug development, announced its financial results for the third quarter of fiscal year 2026…
AltaSea and World Trade Center Barcelona collaborate to accelerate blue economy technologies, ocean-based climate solutions, and global innovation networks. AltaSea at the Port of Los Angeles—recognized globally as a major hub for the blue economy—has announced a new international partnership…
Lifezone secures exclusive rights with the Burundi government to advance development of the Musongati nickel project in East Africa. Lifezone Metals Limited has officially signed an exclusivity agreement with the Government of Burundi covering the development potential of the Musongati…
NYU Abu Dhabi and RTW Investments Forge Strategic Partnership to Advance Healthcare Innovation, Executive Education, and Cross-Sector Engagement in the Middle East ABU DHABI, United Arab Emirates & NEW YORK — NYU Abu Dhabi (NYUAD) and RTW Investments, LP (“RTW”)…
Montrose Environmental Group reports record revenue, earnings, and cash flow for 2025, driven by strong demand across core environmental solutions, and increases its 2026 guidance on continued operational momentum. Montrose Environmental Group, Inc. delivered a standout performance in 2025, reporting…
Agilent Technologies, Inc. reports 7% revenue growth to $1.80 billion, highlighting strong core performance and operational momentum in the first quarter of fiscal 2026. Agilent Technologies, Inc. (NYSE: A) reported a solid start to fiscal 2026, delivering first-quarter revenue of…
Thermo Fisher Scientific Announces 10% Increase in Cash Payout, Strengthening Commitment to Shareholder Returns and Long-Term Growth Thermo Fisher Scientific Inc , widely recognized as the world leader in serving science, has announced that its Board of Directors has authorized…
Aurinia Pharmaceuticals Inc. posts strong 2025 revenue growth and outlines strategic progress across its commercial and clinical pipeline. Aurinia Pharmaceuticals Inc. has reported strong financial and operational performance for the fourth quarter and full year ended December 31, 2025, highlighting…
Asahi Kasei expands into severe infectious diseases with the €780 million acquisition of AiCuris Anti-infective Cures AG, strengthening its specialty pharmaceutical pipeline and global growth strategy. Asahi Kasei has entered into a definitive agreement to acquire all issued shares of…